Uncategorized
VIDEO: Mitro updates Roclatan studies, Aerie financing
NEWPORT BEACH, Calif. ― At the OCTANe Ophthalmology Technology Summit here, Tom Mitro, president and chief operating officer of Aerie Pharmaceuticals, discusses the OCTANe Ophthalmology Technology Summit. He also gives an update on the latest phase 3 studies of Roclatan and the company’s latest round of funding.